Tyrosine kinase pathways and the regulation of smooth muscle contractility
- 30 April 1994
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 15 (4) , 108-114
- https://doi.org/10.1016/0165-6147(94)90046-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The acute actions of growth factors in smooth muscle systemsLife Sciences, 1994
- Tyrosine Kinase Inhibitors Suppress Agonist-Induced Contraction in Smooth MuscleBiochemical and Biophysical Research Communications, 1993
- A protein tyrosine kinase in the interferon αβ signaling pathwayCell, 1992
- Cytokine Receptors and Signal TransductionAnnual Review of Immunology, 1992
- Tyrosine kinase inhibitors and the contractile action of epidermal growth factor – urogastrone and other agonists in gastric smooth muscleCanadian Journal of Physiology and Pharmacology, 1992
- Diacylglycerol lipase and the contractile action of epidermal growth factor-urogastrone: evidence for distinct signal pathways in a single strip of gastric smooth muscleEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Vasoconstrictor‐induced protein‐tyrosine phosphorylation in cultured vascular smooth muscle cellsFEBS Letters, 1991
- Contraction of guinea pig trachea by epidermal growth factor – urogastroneCanadian Journal of Physiology and Pharmacology, 1988
- Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.Journal of Clinical Investigation, 1987
- Modulation by epidermal growth factor – urogastrone of contraction in isolated canine helical mesenteric arterial stripsCanadian Journal of Physiology and Pharmacology, 1986